News

The trial was designed to evaluate the effect of SCV-07 on hepatitis C viral load, as well as on other measures of immune response. SCV-07 demonstrated activity in

Patients in this open label study will be randomized into two dose groups of 28 patients each and will receive a total of six infusions of ofatumumab in

Under the terms of the agreement, Qiagen will supply proprietary QIAplex-based reagents for the multiplex amplification of the most common viruses associated with respiratory infections. Qiagen has previously

Labopharm’s new drug application (NDA) for its novel antidepressant formulation containing trazodone is based on data from five pivotal pharmacokinetic studies and the positive results from its North

The purpose of the Phase III trial is to evaluate the safety and efficacy of unit dose budesonide (UDB) in approximately 360 children from 12 months to eight

Oxygen Biotherapeutics will receive stock in Glucometrics and running royalties on a sliding scale based on worldwide net revenues from products derived from the licensed technology. Under terms

The trial is a double-blind, placebo-controlled, dose-escalating clinical trial evaluating the safety and efficacy of the company’s topical drug candidate, RGN-137, in patients with venous stasis ulcers. There

As part of this potential $136 million development and commercialization collaboration, AstraZeneca and Dynavax have initiated investigational new drug enabling studies with AZD1419 and plan to begin Phase

This key Phase II/III trial data showed that LB03002 in children with growth hormone deficiency (GHD) demonstrates safety and efficacy profiles comparable with existing, daily human growth hormone